Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Emerging Biopharma
Biotech
Syncona cites 'challenging' market for switching investment plan
Life sciences firm Syncona has blamed “particularly challenging” market conditions for shifting its strategy away from early-stage biotechs.
James Waldron
Jun 20, 2025 6:00am
US biotechs must adapt as global competition rises: Antares CEO
Jun 17, 2025 8:15am
Astellas offers lab space to help Japanese biotechs 'go global'
Jun 13, 2025 4:41am
Novo Nordisk inks $812M Deep Apple deal to pursue obesity target
Jun 11, 2025 7:00am
Juri inks $210M T-cell engager deal with China biotech
May 27, 2025 6:00am
Nominations now open for Fierce Biotech's 2025 Fierce 15
May 20, 2025 7:30am
More News
Stylus outlines next-gen gene editing mission with $85M in hand
May 13, 2025 7:00am
Former Inhibikase CEO launches new biotech for Parkinson's asset
May 12, 2025 12:44pm
Tango dances away from preclinical work to extend cash runway
May 12, 2025 8:37am
Versant unveils new autoimmune biotech with $100M fundraise
Apr 24, 2025 8:00am
See more stories
